2 instances of misconduct since 1995 | $6.5M in penalties
Emergent BioSolutions is a biopharmaceutical company that develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and provides medical devices for biodefense purposes.
2 Instances of Misconduct since 1995
Congressional Investigation of COVID Vaccine Manufacturing Failures
Sponn v. Emergent BioSolutions (Shareholder Lawsuit)